VNDA icon

Vanda Pharmaceuticals
VNDA

Overview Fund Activity

187 hedge funds and large institutions have $819M invested in Vanda Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 72 increasing their positions, 63 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
187
Holders Change
+11
Holders Change %
+6.25%
% of All Funds
3.29%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
30
Increased
72
Reduced
63
Closed
17
Calls
$1.84M
Puts
$1.82M
Net Calls
+$25K
Net Calls Change
+$1.81M

Top Buyers

1
EIP
Epoch Investment Partners
New York
$17.4M
2
LSV Asset Management
LSV Asset Management
Illinois
$19.8M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
$11.3M
4
BlackRock
BlackRock
New York
$151M
5
Citigroup
Citigroup
New York
$2.9M

Top Sellers

1
AC
Armistice Capital
New York
$57M
2
Morgan Stanley
Morgan Stanley
New York
$4.01M
3
PAI
Palo Alto Investors
California
$57M
4
ACM
AIGH Capital Management
Maryland
$0
5
Renaissance Technologies
Renaissance Technologies
New York
$55.4M
Name Holding Trade Value Shares
Change 		Shares
Change %
Rockefeller Capital Management
201
Rockefeller Capital Management
New York
– -$6K -500 Closed
PWPS
202
Pinnacle Wealth Planning Services
Ohio
– -$3K -226 Closed
GLLW
203
Graves Light Lenhart Wealth
Virginia
– -$3K -200 Closed
5 6 7 8
9